MarketPeel
Insider Trading Intelligence
JJ

Julie Jordan

NGNE
CHIEF MEDICAL OFFICER · NEUROGENE INC. · CIK 0001968554
FILING MIX · LIFETIME83%/17%
BUYS
5
SELLS
1
TOTAL VALUE
$18.1K
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
12,472
AVG SELL PX
$21.89
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Julie Jordan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-3.36%+1.67%-5.03%-5.03%
14d1+100.00%-0.19%+5.40%-5.58%-5.58%
30d1+0.00%+26.25%+10.67%+15.58%+15.58%
60d1+0.00%+29.43%
90d1+0.00%+47.27%+13.72%+33.55%+33.55%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NGNE · 12,472 shares · as of Mar 26, 2026
018,75037,50056,25075,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 5 buys / 1 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
828$21.89$18.1K12,472Mar 26, 2026Mar 30, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
29,60029,600Feb 20, 2026Feb 24, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
4,90013,300Feb 20, 2026Feb 24, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
8,4008,400Mar 26, 2025Mar 28, 2025View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
50,30050,300Mar 26, 2025Mar 28, 2025View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
75,00075,000Jan 16, 2024Jan 18, 2024View →
Other insiders · NGNE
Loading peer insiders…
About this filer
CIK 0001968554
ROLE
Chief Medical Officer
PRIMARY
NGNE
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0001968554DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback